Following CXCL12 binding, CXCR4 is downregulated on the CLL B cell surface by endocytosis, making the cells less responsive to CXCL12 and allowing their recirculation in the peripheral blood (66). Here, CXCL12 is linked to B-cell chronic lymphocytic leukemia.